Tell your U.S. senators: Stop prescription drug patent abuse
![](https://publicinterestnetwork.org/wp-content/uploads/2023/05/40-80-percent-savings-Patricia-Kelmar.jpg)
The patent system belongs to the American people and exists for our benefit. It’s been critical to spurring valuable innovation in medicine — but unfortunately there exist a number of loopholes that drug companies regularly exploit to abuse the patent system and maintain monopoly prices for their drugs.Take Humira, Abbvie’s brand-name drug to treat rheumatoid arthritis, for example: Humira cost $523 per month in 2002. In 2023, it costs $3,167 per month.Over the next few weeks, the U.S. Senate will be voting on measures to end drug patent abuse tactics. You can make a difference right now by sending an urgent message to your U.S. senators supporting strong federal-level reforms to the patent system.